---
figid: PMC9148017__jcm-11-02947-g005
pmcid: PMC9148017
image_filename: jcm-11-02947-g005.jpg
figure_link: /pmc/articles/PMC9148017/figure/jcm-11-02947-f005/
number: Figure 5
figure_title: ''
caption: 'Interaction between ROE (3 mg/mL) and UDE (A) 0.1 µM) or ROL (B) 1 µM) in
  the context of relaxation of the PCCSM (n = 4). ROE: Rubus occidentalis extract,
  UDE: udenafil, ROL: rolipram, PCCSM: penile corpus cavernosum smooth muscle, UDE
  + ROE: ROE treatment after pretreatment with UDE, ROE + UDE: UDE treatment after
  pretreatment with ROE, ROL + ROE: ROE treatment after pretreatment with ROL, ROE
  + ROL: ROL treatment after pretreatment with ROE. Values are presented as means
  ± standard deviations. * p < 0.05, ** p < 0.001 vs. treatment with UDE or ROL.'
article_title: Rubus occidentalis and Ellagic Acid Affect the Contractility of Penile
  Corpus Cavernosum Smooth Muscle through the Nitric Oxide-Cyclic Guanosine Monophosphate
  and Cyclic Adenosine 3′,5′-Monophosphate Signaling Pathway.
citation: Keshab Kumar Karna, et al. J Clin Med. 2022 May;11(10):2947.
year: '2022'

doi: 10.3390/jcm11102947
journal_title: Journal of Clinical Medicine
journal_nlm_ta: J Clin Med
publisher_name: MDPI

keywords:
- Rubus occidentalis
- ellagic acid
- erectile dysfunction
- udenafil
- rolipram
- nitric oxide
- cyclic guanosine monophosphate
- cyclic adenosine 3′,5′-monophosphate

---
